Aspirin reduces the incidence of cancer in carriers of hereditary colorectal cancer

Published 2011-11-01 00:00. Updated 2013-11-26 10:29

[NEWS 1 November 2011] Professor Annika Lindblom at the Department of Molecular Medicine and Surgery is co-author in a study that shows that regular use of aspirin substantially reduces the incidence of cancer in carriers of hereditary colorectal cancer.

Publication in the Lancet

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Lancet. 2011 Oct 27. [Epub ahead of print]

Contact